Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences.
A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation.
Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority
Program built on institutional assets and centers of excellence
Experienced, professional team
Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation.
Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth
Presentation by Noel Harvey, VP R&D, and Al Lauritano, Head of Strategic Technology Partnerships, Becton Dickinson, on January 19, 2015 for mHealth Israel meetup.
Telehealth Failures & Secrets to Success Conference 2017 by VSee Speaker Series
Karyn DiGiorgio (University of California)
More info at: vsee.com/conference
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in medical tech and asks the experts what it all means.
Key Points:
Multi-million dollar investments don’t always mean success. Success looks different to each stakeholder involved in digital health.
The winners in digital health will be those who provide real solutions to problems at a reduced cost.
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report comprises an in-depth view of the progress of digital health, case studies, along with opinion from some key players in the industry.
Digital health empowers us with ways to improve outcomes and increase efficiency.
Part 2 of our report will look at how we can learn from failures in digital health, available [when available and how to access].
Keynote by Jill Seidman, Director at Healthbox, about US digital healthcare investment trends and opportunities for the mHealth Israel meetup community
Digital Health Success Stories Report - Part 1Tom Parsons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in healthcare technology and asks the experts what it all means.
mHealth Israel_Mony Weschler_Montefiore_How Data Exchange Is Essential In Sup...Levi Shapiro
Presentation for mHealth Israel by Mony Weschler, Senior Director Applications Strategy and Innovation, Albert Einstein College of Medicine, Montefiore Medical Center. Theme: How Data Exchange Is Essential In Support of New Technologies & Healthcare Innovation. This presentation has three objectives:
1) Discuss IT governance components that positioned Montefiore to achieve extensive community outreach efforts
2) Review strategies for incorporating innovation and new technologies into existing processes.
3) Identify the data exchange challenges
Presentation by Noel Harvey, VP R&D, and Al Lauritano, Head of Strategic Technology Partnerships, Becton Dickinson, on January 19, 2015 for mHealth Israel meetup.
Telehealth Failures & Secrets to Success Conference 2017 by VSee Speaker Series
Karyn DiGiorgio (University of California)
More info at: vsee.com/conference
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in medical tech and asks the experts what it all means.
Key Points:
Multi-million dollar investments don’t always mean success. Success looks different to each stakeholder involved in digital health.
The winners in digital health will be those who provide real solutions to problems at a reduced cost.
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report comprises an in-depth view of the progress of digital health, case studies, along with opinion from some key players in the industry.
Digital health empowers us with ways to improve outcomes and increase efficiency.
Part 2 of our report will look at how we can learn from failures in digital health, available [when available and how to access].
Keynote by Jill Seidman, Director at Healthbox, about US digital healthcare investment trends and opportunities for the mHealth Israel meetup community
Digital Health Success Stories Report - Part 1Tom Parsons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in healthcare technology and asks the experts what it all means.
mHealth Israel_Mony Weschler_Montefiore_How Data Exchange Is Essential In Sup...Levi Shapiro
Presentation for mHealth Israel by Mony Weschler, Senior Director Applications Strategy and Innovation, Albert Einstein College of Medicine, Montefiore Medical Center. Theme: How Data Exchange Is Essential In Support of New Technologies & Healthcare Innovation. This presentation has three objectives:
1) Discuss IT governance components that positioned Montefiore to achieve extensive community outreach efforts
2) Review strategies for incorporating innovation and new technologies into existing processes.
3) Identify the data exchange challenges
Harnessing the Power of Healthcare Data: Are We There YetHealth Catalyst
What can healthcare learn from Formula One racing? According to Dr. Sadiqa Mahmood, SVP of medical affairs and life sciences for Health Catalyst, race support teams leverage about 30TB of baseline data to create a digital twin of the car, track, and racer for simulation models that drive decisions at each race. Applied in the healthcare setting, a digital twin can help clinicians better understand each patient and their health conditions and circumstances in real time and make comprehensive, informed care decisions. But for the healthcare digital twin to happen, the industry must move away from data silos and towards a digital learning healthcare ecosystem.
Healthcare Everything’s latest edition “10 Most Trusted Healthcare Consulting Firms” have shortlisted a few healthcare consulting firms that are pivotal in driving positive change and innovation within the healthcare industry.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Aami hitech mu impact on the future on HC ITAmy Stowers
Relate the components of The HITECH Act and Meaningful Use to health management technology
Identify whether existing systems meet requirements
Communicate technology needs and request feedback from end users for a smooth transition
Implement best practices to move people and systems forward under these new requirements
MedClerx has been gaining traction for the past year with two major radiology centers in Orange County considering our software to facilitate health information exchange.
Our team is proud to be supported by the UCI Applied Innovation's Wayfinder Incubator.
The 20 most disruptive healthcare solution providers 2018insightscare
With an idea to acknowledge the fast-growing companies, contributing extraordinarily to the revolution of disruption in healthcare, we bring to you the special edition of “The 20 Most Disruptive Healthcare Solution Providers 2018”.
10 Best Healthcare Solution Companies in 2022.pdfinsightscare
Enabling a plethora of such exemplary traits and combining them with innovative solutions, Insights Care features the “10 Best Healthcare Solution Companies in 2022” that are transforming the healthcare niche and reshaping the future of healthcare delivery with a novel approach.
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform removes silo barriers to connect, aggregate and integrate disparate data from mHealth applications and Remote Patient Monitoring (RPM) devices.
Our services provide HIPAA secure data to the “point of care” wherever the clinician is located. Enabling clinicians to rapidly respond to clinically relevant patient health information can facilitate early interventions, reduce hospital admissions, improve outcomes and lower costs.
Our passion empowers us to create eHealth collaboration tools that enhance provider efficiencies, track outcomes and improve the quality of life for patients throughout the continuum of care.
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
More Related Content
Similar to Baptist Health- Engineering the Future of Healthcare
Harnessing the Power of Healthcare Data: Are We There YetHealth Catalyst
What can healthcare learn from Formula One racing? According to Dr. Sadiqa Mahmood, SVP of medical affairs and life sciences for Health Catalyst, race support teams leverage about 30TB of baseline data to create a digital twin of the car, track, and racer for simulation models that drive decisions at each race. Applied in the healthcare setting, a digital twin can help clinicians better understand each patient and their health conditions and circumstances in real time and make comprehensive, informed care decisions. But for the healthcare digital twin to happen, the industry must move away from data silos and towards a digital learning healthcare ecosystem.
Healthcare Everything’s latest edition “10 Most Trusted Healthcare Consulting Firms” have shortlisted a few healthcare consulting firms that are pivotal in driving positive change and innovation within the healthcare industry.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Aami hitech mu impact on the future on HC ITAmy Stowers
Relate the components of The HITECH Act and Meaningful Use to health management technology
Identify whether existing systems meet requirements
Communicate technology needs and request feedback from end users for a smooth transition
Implement best practices to move people and systems forward under these new requirements
MedClerx has been gaining traction for the past year with two major radiology centers in Orange County considering our software to facilitate health information exchange.
Our team is proud to be supported by the UCI Applied Innovation's Wayfinder Incubator.
The 20 most disruptive healthcare solution providers 2018insightscare
With an idea to acknowledge the fast-growing companies, contributing extraordinarily to the revolution of disruption in healthcare, we bring to you the special edition of “The 20 Most Disruptive Healthcare Solution Providers 2018”.
10 Best Healthcare Solution Companies in 2022.pdfinsightscare
Enabling a plethora of such exemplary traits and combining them with innovative solutions, Insights Care features the “10 Best Healthcare Solution Companies in 2022” that are transforming the healthcare niche and reshaping the future of healthcare delivery with a novel approach.
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform removes silo barriers to connect, aggregate and integrate disparate data from mHealth applications and Remote Patient Monitoring (RPM) devices.
Our services provide HIPAA secure data to the “point of care” wherever the clinician is located. Enabling clinicians to rapidly respond to clinically relevant patient health information can facilitate early interventions, reduce hospital admissions, improve outcomes and lower costs.
Our passion empowers us to create eHealth collaboration tools that enhance provider efficiencies, track outcomes and improve the quality of life for patients throughout the continuum of care.
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
Similar to Baptist Health- Engineering the Future of Healthcare (20)
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
mHealth Israel_Healthcare Finance and M&A- What Comes NextLevi Shapiro
Healthcare Finance and M&A, What Comes Next? Presentation by Matthew R. Kittay, National Co-Chair, M&A Practice Group, Fox Rothschild LLP. Includes fundraising and investments. Breakouts by subsector- Healthcare (overall), Healthcare services, Digital health, Biopharma, Pharmatech, Medtech, Healthcare IT. Healthcare transaction distribution breakouts. Exits remain flat. Avoiding common legal pitfalls like IP, compliance, governance structure. Current legislation in health law. IP strategy for healthtech.
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...Levi Shapiro
Oppenheimer & Co. Inc, co-Head of Healthcare Investment Banking, Michael Margolis, provides H1 Healthcare Financing, Funding and M&A Overview. Table of Contents
1. Broader Market Overview
2. Biotech M&A Market Overview
3. Private Biotech Financing Market Update
4. Key Advice For Healthcare Companies
Current State of Play; Healthcare has Underperformed the Broader Market Over the Last Twelve Months; Signal-to-Noise is Getting Worse; Healthcare IPO Activity has Decreased Significantly Since 20–21 Pandemic Levels; Biotech Financing Activity Has Remained Robust in 2024; Biotech M&A Market Remains Incredibly Active; Biotech M&A Market Remains Incredibly Active; Big Pharma Upcoming Patent Expirations; Since November 2023 Oncology has accounted for over half of all M&A; Oncology, Autoimmune / I&I, and CV & Metabolic Remain the Top Areas in M&A; Small Molecule Beats Out All Other Modalities in M&A Despite IRA Concerns; Value of Big Pharma Acquisitions by Therapeutic Area in Q1 2024; Private Financing Market Update; 2024 Private Placement Activity On Track to Approach, If Not Exceed, 2020 Levels; Oncology, Particularly Solid Tumor, Continues to Attract VC Investors; Despite the IRA, Small Molecules Continue to Attract VC Dollars; Preclinical-Stage Companies Make Up Almost Half of Private Placements in 2023; Valuations by Development Stage – 2023; Typical Biotech Investors Remained Active in Q1 2024; 23 $100M+ Deals were Raised in Q1 2024; Biotech Fundraising Momentum Continued into 2024; Key Advice For Israeli Healthcare Companies; Although Israel has Strong Presence on US Public Markets, There is Room to Grow; Telling Your Story Effectively; Interacting with Investors to Build Long-term Credibility; Seven Simple Rules for Pitch Decks;
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003Levi Shapiro
Description of the Version Bravo intensive entrepreneurial launch program for 7 Israeli and 7 US former Navy SEALs. Details about each startup concept, the CEOs, the sector, etc.
Radical Life Extension_Dr. Leon Peshkin_Dec 2023Levi Shapiro
Presentation for mHealth Israel by Dr. Leon Peshkin, Harvard Medical School, exploring research into Embryology and Longevity, emphasizing Germline and protein aggregates. Includes current overview, anti aging through history, Lifespan Expansion, ALEC: Animal Life Expectancy in Controls, Scalable Platform in Pharmacobiology, Embryos Cleanse Protein Aggregates, Lysosomal switch triggers proteostasis renewal, Xenopus, Rejuvenation Roadmap, Citizen Science Approach to Aging, Xenopus: Maternal Dowry Molecules, Human Disease Modeling
Israel’s Life Science Hub 2023 English Abstract.pdfLevi Shapiro
The war between Israel and Hamas brings its own set of business
challenges. Challenges that may impact how we communicate with
partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize:
1) Global activity (resilience and agility)
2) Continuity of care and preventive medicine
3) World leading clinical trials industry
4) Dynamic scientific, research and entrepreneurial ecosystems
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...Levi Shapiro
The Future of Digital Health – Nose Dive or Transformation, by Gil Bashe, Dec 4th, 2023 at the mHealth Israel conference. Digital Health Innovation Ecosystem Investment Trends. Data & Methodology. Digital Health Taxonomy. Key Insights for Digital Health Innovation in H1 2023. Global Digital Health Funding Across Regions. Funding in North America. Shifting Focus in North America Digital Health Funding. Investment Focus for Digital Health Venture Funding. Ventures are turning to partnerships for proof points, scale and funding. 2022 new partnerships. North America digital health investor participation. Most active partners in North America. North America Ecosystem Development. Venture distribution by stage. Funding distribution. Comparison to 2022 Funding. Noteworthy deals, noteworthy exits.
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MITLevi Shapiro
We, 465 MIT Alumni, Staff, and Students, are writing to express our deep concern, fear, and disappointment regarding the recent protest that took place Thursday afternoon, in front of the MIT Stratton Student Center. While we fully support the principles of free
speech and the right to peaceful assembly, it is essential that we also prioritize the safety and well-being of all members of the MIT
community.
During the protest, a particular slogan was prominently displayed and chanted, which has raised significant concerns. The slogan
"From the [Jordan] river to the [Mediterranean] sea, Palestine will be free!" has been a source of contention due to its potential
implications and the real safety risks it poses to Jewish and Israeli students on campus [See video footage attached]. This slogan
has been time and again associated with calls for the destruction of the State of Israel and has been used in contexts that
promote violence, which raises legitimate concerns about the safety and security of our Jewish and Israeli students and staff.
Furthermore, we would like to draw your attention to recent events that demonstrate the potential dangers associated with this
slogan. During the 2023 Israel-Hamas war, British Home Secretary Suella Braverman proposed criminalizing the use of the slogan
in certain contexts, recognizing the potential harm it can cause. Additionally, on October 11, ‘23, Vienna police banned a
demonstration, citing the inclusion of the phrase "from the river to the sea" in invitations, as it was seen as a portrayal of a violation
of Article 2 of the European Convention on Human Rights.
In addition to the use of these derogatory messages, several attendees of the event used hateful wordings and messages towards
Jewish and Israeli bystanders. In one case, a perpetrator aggressively held their bicycles as intended to harm a Jewish MIT student,
stating that “[your] ancestors did not die in the Holocaust so they could kill Palestinians” [See video footage attached]. In another
incident, protesters chanted “one solution, intifada revolution”. In the context of the on-going Israeli-Palestinian conflict, the word
"Intifada" means the armed and violent Palestinian insurrection targeting Israelis, including civilians, which resulted in the killing of
thousands of Israelis in the last few decades.
On Oct. 22nd, a statement by MIT CAA (Coalition Against Apartheid) came to our attention. In this document, MIT CCA states that
they "hold the Israeli regime responsible for all unfolding violence". They later call the October 7th terror attack a "response to
the settler colonial regime", and continue justifying it throughout the document.
In this matter, MIT CAA is justifying the heinous and barbaric crimes committed on Oct 7th. Furthermore, these statements have the
potential to fuel acts of aggression
Overview of the Israeli exhibitors at the 2023 HLTH conference in Las Vegas. Exhibitors included 6Degrees, AppScent, Belong.Life, Datos, Expecting, IntraPosition, Kahun Medical, Kemtai, Maverick, Neteera, QuantaIX, Respiration Scan, Nerivio, Xoltar.
40% of Israeli technology investment is devoted to Life Science. Within that domain, the largest sector is Medical Devices and Digital Health (over 65 percent of companies). In the medical device arena, Israeli scientists and engineers have integrated advanced technologies in electronics, communications and electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostics,
Smart Surgical Equipment and more. Over 600 medical device exporters engaged in a variety of medical application
such as Cardiovascular and Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency
Medicine, Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control, Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...Levi Shapiro
Presentation by Yael Klionsky, YEDA, for the mHealth Israel community in September, 2023. Title: Challenges in Academic Technology Transfer. Examples-
Transplantation Immunology and Immunometabolism. Efranat Pharma was developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. From target discovery to clinical validation. Clinical-stage drug discovery and development company utilizing a broadly applicable, predictive
computational discovery platforms to identify novel drug targets and new biological pathways and develop
therapeutics in the field of cancer immunotherapy. To allow SOCIETY to benefit from discoveries made at the academic institution. To enable SCIENTISTS to transfer their new technologies to the market. To create an additional source of INCOME for the INSTITUTE so that more independent research can be conducted. Three important elements that make an idea patentable:
1) The invention must be new: the same idea can’t have been
published before in any form; 2) There must be some inventive step of ‘non-obviousness’.
This can be hard to define and depends on the context; 3) The disclosure in a patent must be sufficient for a skilled
person to reproduce the invention with only routine effort; Technology Transfer Company - modus operandi; OUR PURPOSE- To provoke transformative scientific breakthroughs that will shape the future of humanity; SCIENTIFIC STAFF- 300 Principal investigators, >2,000 Research students and PhDs; 5 FACULTIES – BASIC SCIENCE, Biology, Physics, Biochemistry, Math/CS
Chemistry; Generated IP- 57% in Life Science & Biotech; Among the Highest
Income per Researcher
Worldwide; 1959 (First TTO outside the US); Today- More applications per PI than in most Ivy league universities; Copaxone- >$30B
ANNUAL SALES BASED ON Weizmann IP; 20 new licenses per year and 10 new companies per annum; www.yedarnd.com
HADASIT: Tech Transfer and More in Life ScienceLevi Shapiro
Overview of activities in Life Science of Hadasit, the technology transfer arm of Hadassah Hospital in Jerusalem. Includes details about Jerusalem Biodesign program; spinouts like Brainwatch; details about tech transfer (the Secret Engine Behind Israel’s Success); relationship and examples of TTOs enabling Israel's greatest success stories; contrasting of Adademia (Scientific driven research, Creation of new knowledge, Publication, Sharing of Material, Social responsibilities) and Industry (Applied research & specific objectives, Develop new products, Product development, Secrecy and patent protection, Organization responsibilities); Development gap between initial inventions and product development; the Art of translation (from academic research to medical companies); Tech transfer transforms cutting-edge research into marketable healthcare technologies; LICENSING TO EXISTING COMPANIES; SPINNING OFF STARTUPS; CO-DEVELOPMENT OF JOINT IP; Technology Transfer Offices from Academia/Research Hospitals – to Industry; Overview of Hadassah and Hadasit (TECHNOLOGY TRANSFER COMPANY AND INNOVATION ENGINE OF HADASSAH UNIVERSITY HOSPITALS); Examples of “HADASSAH MADE” PRODUCTS IN THE GLOBAL MARKET; RECENT TECH TRANSFER SUCCESS; Example- Lineage Exclusive Worldwide Collaboration with Genentech Opregen® RPE Cell Therapy for the Treatment of Ocular Disorders; HADASIT PILLARS-
NURTURING INTERNAL INNOVATION, Tech Transfer, EXTERNAL INNOVATION. External- SERVICES & COLLABORATIONS WITH COMPANIES, BIOHOUSE FOR STARTUPS, DIGITAL HEALTH ACCELERATOR); Internal Innovation- NURTURING INTERNAL INNOVATION, HADASSAH SEED FUND, JERUSALEM BIODESIGN PROGRAM; TYPES OF RELATIONS WITH EXTERNAL COMPANIES- CONSULTING, SAB, CLINICAL TRIALS, R&D SERVICES, DATA LICENCE, ALPHA/BETA SITE, PILOTS, DESIGN PARTNERSHIPS.
Presenting to Investors & the Media.pdfLevi Shapiro
Presenting to Investors and the Media, lecture by Drew Levinson, LifeSci Communications to mHealth Israel. Three sections: Making a good presentation, Handling
interviews with reporters and Answers that resonate. PRESENTING TO INVESTORS AND THE MEDIA- Compelling delivery, Commanding a room, • Lasting Impact. A good presentation includes Information, Motivation and Excitement. Never put them to sleep. Audience impact includes content, credibility and delivery. Decisions are made leading to potential partnerships, winning business, so much more than a deck, your business, your brand, you. How to captivate begins with storytelling and conversation. More than features- benefits, humanize, positive impact. Don't complicate your message with jargon. Feel the passion- contagious, vision, determination. Know your audience- who are they, what do they know about you, how much do they know, interests, concerns. Articulate your vision- see it, feel it, believe in it. Take them on your journey- compelling narrative, make it personal, why are you doing this, inspiration. Your team- experienced, knowledgeable, aligned, execute. Risks and challenges- recognize, address, plan to mitigate. Test drive your room. What does it look like? Where is the podium? Where will I be standing? Where will you be sitting? Feel comfortable. Three parts to attention. The beginning- attention, interest, what's in it for them, entusiasm, preview. The middle- core, insights, challenges, solutions, relatable. The ending- summary, reinforce, messages, benefits, call to action, keep the momentum going. How to answer questions. The Four R's: repeat, reinforce, refer, remember. Talking to reporters- necessity; Good interview can enhance reputation; Bad interview can tarnish reputation; Preparation is vital. Shapes public opinion: Elevates your brand; Establishes authority; Showcases your business; A bridge; Reputation; Trust; Visibility. Know the reporter. Audience; What have they written; Previous stories; Questions asked. Concise- clear, succinct, engaging. Make it relatable: Stories; Anecdotes; Experiences; Examples; Metaphors; Connect. Honesty and transparency. It is okay not to know every answer. You don’t have to answer every question. Control the narrative. What not to do when talking to reporters. Come up with another way to say no comment. What to wear- solid colors, blues and grays, nothing distracting. Expertise, passion, vision, lasting impression, connections. High stakes, high rewards. Preparation; Know your audience; Deliver with confidence; Enthusiasm; Authenticity. Begin the journey. Engage in dialogue; Build relationships; Inspire trust and confidence; Valued; Enlightened; Motivated and excited.
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...Levi Shapiro
Presentation by Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgical Navigation Company and What's Next for XR. Covers the company founding across multiple milestones and key success factors.
Beyeonics CEO, Ron Schneider, Advances in Medical XRLevi Shapiro
Overview by Beyeonics CEO, Ron Schneider, about the company. Beyeonics One is the first ophthalmic exoscope with an augmented reality surgical headset. It is a high-definition, fully digital imaging platform enabling surgeons to see a magnified, three-dimensional (3D) image of the surgical field. The small footprint, the fast setup, automation, and zero turnover time between procedures all contribute to the efficiency operating rooms strive for. Over 3000 cases to date. Unconstrained Movement. Unconstrained workflow. Data connectivity. Designed for continuous innovation.
XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. Includes a description of the TeleHealth Platform. Lessons Learned – Building the clinical Metaverse. Last mile delivery
Building a product in the Metaverse is easy – getting people to use it is hard. Virtual Care can’t be based only on XR. HMDs bring friction – Charging, Guardian, Safety, Passwords etc. Expanding virtually in a brick & mortar payer environment. Once you cross the chasm – adherence/ satisfaction/retention goes ballistic. Patient Outcomes-
Patients report significant improvement in symptoms following treatment. Adherence - patients follow Home Exercise Plans as prescribed. 92.2% with XRHealth vs 50% with regular treatment. Patient satisfaction - 85 NPS vs 38 NPS in healthcare
93.3% patient retention -complete treatment cycle as prescribed. XRHealth Luna AI Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial. Lessons Learned – Autism Spectrum Disorder. The future of the Mediverse.
Digital Health in US Health Systems.pptxLevi Shapiro
April, 2023 presentation by Gil Bashe, Global Chair, Health Practice, FINN Partners. Insights and analytics, in collaboration with Galen Growth, tracking Digital Health collaboration, adoption, integration, and best practices across the leading US Health Systems. There is a section about focus areas for digital health in health systems and hospitals. The most active health systems are partnering more in diagnosis and have a higher share of digital tools for research. Comprehensive breakout of digital health activities at the Top 10 players: Mayo, Mount Sinai, Cleveland Clinic, Sloan Kettering, Massachusetts General, Northwell, Cedars Sinai, Brigham & Women's, InterMountain. Global breakout of health systems with digital health partnerships at scale. Geographical breakout of digital health partner headquarters (by region). Strong preference for B2B business model. 1/3 of digital health partnerships with Early Stage venture companies. Emphasis is on strong clinical evidence. Portfolio size allows greater diversity. Cluster distribution depends on therapeutic area. Digital health analytics breakout including alpha score, venture similarity score, venture valuation, team signal, partnership signal, evidence signal.
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...Levi Shapiro
Syllabus for the Future of Digital Medicine course, 2023- Biology, Genetics, Technology and BioInformatics. Includes lectures from Noam Shomron, Michal Rosen-Zvi, Eyal Zimlichman, Gila Tolub, Dana Bar-On, Yesha Sivan, Vladi Dvoryis, Varda Shalev, Avi Schroeder, Christian Tidano, Eyal Toledano.
Alagene BioFoundry: Releasing the Genie Out of the Bottle Levi Shapiro
Overview of Israel's leading BioFoundry, Alagene by Roni Cohen, CEO. Overview of Synthetic Biology- Taking biology into engineering mode. Using synthetic genes, to program cells to become factories to make devices, sensors, pharmaceuticals, renewable chemicals, fuels and food. Alagene has four partners with complementary expertise. Hylabs is an established and experienced, highly regulated service company. Reichman University is an academic partner with a commercialization mindset. The Israel Innovation Authority is the government and Aleph VC is an investment firm. Alagene is a home for innovation and R&D center in SynBio, serving as a one-stop—shop for knowledge, methods, and instrumentation to enable our customers in Israel and worldwide to get to their proof of concept. Alagene is anend to end Infrastructure supporting gene & host optimization in microbial systems. The infrastructure enables two Major Implementations- Biomanufacturing and Direct Microbial Application. One example is the development of a Dairy Milk Producing System, using Genetic Optimization and Process Optimization and Validation. Finally, Alagene shared the following recent project examples: Computational prediction for introducing new genes into microbes; Precision fermentation for yeast producing dairy proteins; Bio production of psychoactive / cannabinoid molecule in yeast; Bio production of growth factors for the cultured meat industry; Developing new inhouse tools to support strain optimization; Bio production of egg protein; Computational modeling of full metabolic network in Algae; Bio production of rare sugars with a low glycemic index.
Digital Health Ecosystem- 2022 3rd Quarter ReportLevi Shapiro
Snapshot of the global digital health investment and innovation landscape, Q3 2022, prepared by FINN Partners and Galen Growth. Includes digital health funding history, 2021 digital health investment funding breakouts, winners and losers in 2022 digital health venture funding, global vernture disribution by therapeutic area, venture distribution by stage, regulatory filings by digital health area, change in venture funding by therapeutic area, global digital health funding across regions, top funded therapeutic areas, venture funding in key digital health innovation clusters and geographies, digital health funding across regions, 2022 digital health in Israel, QoQ digital health funding by region, QoQ digital health funding, five year trended digital health funding across regions, noteworthy exits in MENA, M&A, Medigate, Breezometer, AIDOC, Vayyar, Viz.ai, Cathworks, Hello Heart, Israel venture funding and exits
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. 2
Employees:
24,000+
Physicians:
4,000
Outpatient centers,
urgent care facilities
and physician practices
150
Hospitals:
12
• Baptist Health has internationally renowned
centers of excellence in cancer, cardiovascular
care, orthopedics and sports medicine, and
neurosciences.
• A not-for-profit organization supported by
philanthropy and committed to its faith-based
charitable mission of medical excellence,
• Recognized by Fortune as one of the 100
Best Companies to Work For in America
and by Ethisphere as one of the World’s
Most Ethical Companies.
Baptist Health South Florida
3. 3
Innovation Matters
• Innovation is paramount to health system’s performance and reputation.
• Becker’s 2019 Advisory Board survey revealed innovation and
technology ranked as the top priority among healthcare finance
professionals - up from eighth in 2018.
• 90% healthcare/life science leaders agree that the pandemic will
fundamentally change the way they do business, requiring new
products, services, processes, and business models
(McKinsey: McKinsey Healthcare Innovation Through Crisis Survey).
5. 5
Innovation as a strategic,
institutional priority
Program built on institutional
assets and centers of excellence
Experienced, professional team
Technology development
and sourcing
Dedicated, long term support
Successful Programs - Common
Underpinnings
6. 6
Seasoned Healthcare Innovation Team
Barry T. Katzen, M.D.
Chief Medical Innovation Officer
Mark Coticchia
Corporate Vice President
Nila Bhakuni
Assistant Vice President
Joseph Jankowski, Ph.D.
Senior Advisor
Brittany Shaffer, MBA
Senior Advisor, Market & Operations
Walter DeForest
IP Transactions Counsel
Carrie Price
Project Manager
Daeanne Alvarez Cruz
Executive Asst 2
7. 7
Services
Focus on the internal drivers of invention
• Education & Training
• Prototyping & Proof-of-concept
Technology Management
Focus on the commercialization of internal inventions
• Intellectual property
• Opportunity assessment and business case/plan development
• Contractual compliance
• Commercial deal-making
Corporate Co-Creation
Focus on connecting external opportunities for mutual benefit
• Co-development, beta test and potential adoption
• Strategic or opportunistic relationships
Global Medical Service Lines & Facilities
Focus on licensing our technologies and know-how to global market
• Packaging & licensing our know-how, services lines, (e.g. education & training,
work-flows, protocols, procedures)
• Bring cutting-edge technologies/ companies to the U.S. for mutual benefit
Programs
8. 8
What Makes Us Unique
Focus on
market
opportunity
vs.
technology
Select &
concentrate
on winners
Operate
as a
business
Proactive
in new
company
formation
9. 9
Progress
• Baptist Health is on its way to becoming a top
healthcare innovator in the nation.
• Fortune named Baptist Health on its 2023 list of
America’s Most Innovative Companies.
• Ranked #16 out of 57 hospitals and health systems in
the country, and the only Florida-based system.
11. 11
Milestones
2019 2020 2021 2022
Hired first Corporate Vice
President for Innovation
Entered major
codevelopment
deal with Philips
First commercial
IP licenses
Negotiated Master
Research and
IP agreement
with FIU
Strategic venture
capital investment
into Triventures
Led healthcare
technology
innovation network
in South Florida
Adopted first Baptist
Health IP Policy
Led national syndicate
investment into cancer
data company
Entered major
license deal with
stem cell provider
Launched
Innovation Fund
Launched first
start-up company
Executed
codevelopment
deal with Fujitsu
Executed first
international
license
Invested in
Cleerly, a
cardiology AI
company
Launched second
cohort of Knight
Fellowship
2023
Awarded 1st patent
by USPTO
Launched Knight
Fellowship
Built new team
Named first
chief medical
innovation
officer
First
Revenue
13. 13
EXPERTISE,
KNOW-HOW
INVEST
INVENTION DATA
TEACH/
LEARN
CODEVELOP /
USE
CONSULT
LICENSE
Improving Treatment for Cancer Patients
Brings clarity to
cancer care.
COTA organizes
real-world data to
guide clinical
decisions and
actions. Leonard Kalman, M.D.
Benefits & Results
Improved treatment for cancer patients
Royalty revenues
ROI
COTA
Center of Excellence
MCI
Baptist Health uses the breakthrough COTA technology
in its own treatment of patients, is codeveloping the
technology, is an investor, and sits on the board.
MONETIZING IP & DATA
14. 14
EXPERTISE,
KNOW-HOW
INVEST
INVENTION DATA
TEACH/
LEARN
CODEVELOP /
USE
CONSULT
LICENSE
Predicting & Preventing Heart Attacks
Jonathan Fialkow, M.D.
CLEERLY
Predicting heart
attacks with
interpretive reports
from coronary CT
scans.
Ultimately, Cleerly
will have a product
for benchmarking the
progression of heart
disease and enabling
interventions to
prevent heart
attacks.
Center of Excellence
MCVI
Benefits & Results
New patient tool for predicting, preventing heart
disease
Royalty revenues
ROI
Baptist Health has a royalty-bearing license to provide Cleerly
with deidentified data from the Miami Heart Study and to
codevelop the technology. Baptist also has an equity stake.
MONETIZING IP & DATA
15. 15
EXPERTISE,
KNOW-HOW
INVEST
INVENTION DATA
TEACH/
LEARN
CODEVELOP /
USE
CONSULT
LICENSE
Improving Outcomes in Cardiac Care
Jonathan Fialkow, M.D.
Center of Excellence
MCVI
LYNX.MD
Center of Excellence
MCVI
Benefits & Results
Improved insight into cardiology data
Warm intros to data licensees
Additional collaboration opportunities
Downstream licenses & royalty revenues
Baptist Health has a non-exclusive license where Lynx.MD
makes introductions to cardiology companies that may
benefit from Baptist Health patient data (and thus may desire
future licenses with Baptist Health).
A platform that
connects healthcare
partners with real-
world clinical and
operational data
to drive better
outcomes in cardiac
care.
Lynx.MD, an Israeli
company, provides a
secure data network
and medical
intelligence platform
for cardiology data.
MONETIZING IP & DATA
16. 16
EXPERTISE,
KNOW-HOW
INVEST
INVENTION DATA
TEACH/
LEARN
CODEVELOP /
USE
CONSULT
LICENSE
Enhancing a Culture of Innovation
at Baptist Health & South Florida
Benefits & Results
EDUCATION & TRAINING
KNIGHT
FOUNDATION
FELLOWSHIP
$1M grant to establish
program in healthcare
technology innovation.
Raised an additional $1M
in matching funds.
Knight’s largest award to
a healthcare institution
Professional development
program to produce next-
gen innovators
June 2022 –
Graduated inaugural
class, 26 Fellows
Fall 2022 – Second
cohort, 42 Fellows
A teaching/learning program the provides
expertise and know-how.
Lifelong learning for Baptist & community
Innovation curriculum and skills
>200 innovators to lead regional innovation
Classes consist of Baptist
Health staff and South Florida
community members
Teaching includes
contributions from
experienced teaching staff
(Stanford, CWRU, etc.)
17. 17
Investing in Our Future
COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to
cancer care
Date: November 2020
Triventures is a global multi-stage venture capital fund investing in transformational health,
the convergence of big data, healthcare and technology. The firm invests in early and mid-
to-late start-ups that offer data-driven innovations in areas such as genomics, ecommerce
health services, wellness, robotics, decision support, cyber security for healthcare and
disruptive medical devices and diagnostics
Date: November 2021
Cleerly is a digital healthcare company that designs intelligent clinical technologies to help
clinicians precisely identify and define heart disease
Date: July 2022
Investments Details
INNOVATION
FUND
18. 18
Summary
• Innovation is paramount to health system’s performance
and reputation.
• Baptist Health has established an innovation function
predicated on best practices and tailored to its assets and
the opportunities extending from Miami’s economic growth.
• We focus on collaboration, co-development, investment and
cultural enhancement.
Editor's Notes
Thanks for the opportunity to present to you today about Baptist Health South Florida and its emergence as a global innovation leader.
Over the next 15-20 minutes, I will introduce you the health system, explain the importance of innovation to Baptist, and then share information on the dedicated innovation team, some of its approaches and some of its success to date.
I will start by sharing Baptist’s role as a premier medical system.
As you’ll see here, Baptist has grown to now encompass 12 hospitals and 150 clinical sites.
Accordingly, It serves an important position as a key provider to the South Florida population that is growing and aging.
To deal with the healthcare requirements of this population, Baptist has invested into the establishment of progressive health institutes that address key chronic disease conditions in the cardiac, cancer, neural, and orthopedic sectors.
We are proud that Baptist has been long recognized for not only its care, but its values. As the slide presents, we were recently designated as a top-100 company to work for and as one of the world’s most ethical companies.
As I’ll share in a few moments, such accolades are now being extend to our emerging innovation capabilities.
Having shared that Baptist in an important and capable healthcare entity serving South Florida, I want to now share that INNOVATION is an important function of any dedicated healthcare entity.
While it seems obvious that innovation, as a driver of improvement can positively impact one’s care and reputation, its importance is growing.
The 2019 Advisory Board survey of healthcare finance professionals designated innovation as their top priority, while 90% of leaders believe that the post-pandemic provision of care will require and IMPART innovation in the way they do business.
Fortunately, as I will now share, Baptist Health committed to such innovation in the latter-part of the last decade, culminating with my recruitment and the establishment of its first formal innovation function.
Since most of us are are in the field of innovation, it may seem obvious as to “WHY” any hospital system would benefit from an innovation function.
But, remember we, and particularly Sheba ARC, are forerunners to an emerging role for innovation.
At the risk of stating the obvious, I want to suggest to you that Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment
They enhance the reputation through recognition for discoveries made at and through Baptist Health
They aid in the recruitment and retention of top talent
And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues.
We think an innovation function is a sine qua non for any serious, or major, healthcare organization.
So when I established Baptist Health Innovations in late-2019, just intime for the global pandemic, of course, I built the function around the tenets shown as the top four bullets here, with hopes that bullet 5 would follow.
I positioned our activities as a direct contributor to the System’s strategy and growth. Note we did not ‘outsource’ innovation or separate from the central leadership.
I focused our outreach and sector goals on the areas where Baptist was performing best and investing the most – these are our Centers of Excellence defined as the four clinical institutes I introduced early.
People matter – right? RIGHT. So, I ‘brought the ban back together’ by engaging the trusted innovation professionals with whom I have worked for decades at premier intuitions that include Carnegie Mellon University, Cleveland Clinic and Henry ford Health.
I cannot tell you how important this is. Think about it, prior to my recruitment, Baptist didn’t even have an innovation function, or an Intellectual Property Policy, for that matter. Withing a few months, our innovative clinicians and admins were being served by noteble innovation leaders. On the next sldie, I’ll quickly present our team.
Finally, I committed to innovation through both internal development and sourcing of external opportunities. The latter being why we spend so much time and mind share in Israel.
Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more.
The people you see on this slide possess, collectively, the deep expertise I just mentioned. It is however an extremely lean team, and if I have one concern about our mission, vision, and goals, I would say it is that having such a lean team is in some ways a “pulling rabbits out of hats” people plan.
The team has over 100 years combined experience at University of Pittsburgh, Carnegie Mellon, Harvard, Case Western Reserve, MIT, Baptist Health, other health systems, and much more.
I humbly share with you that we are doing very well.
Last year, we were named to Fortune's Most Innovative Companies ranking, showing as number 16 of 57 cited hospitals in the US.
Not too shabby for an enterprise that didn’t have a formal function in 2019.
We are pleased with our progress to date
We have conducted 544 transactions. We have seen 185 inventions that are mostly medical devices, digital and data, and other know-how.
We have conducted 8 codevelopment collaborations. These are with regional non-profits and universities and global healthtech companies like Philips and Fujitsu.
We have done 11 license deals that generate royalties.
We have spun off the first ever Baptist spin-off, a company called Gait Boost.
We recently got the first-ever issued patent at Baptist Health.
And we have put or are putting 68 people through our Knight Fellowship program, a comprehensive professional development program focused on the innovative arts. We developed a curriculum that aligns healthcare needs with commercialization activities, and we taught it to dozens of Baptist Health employees and others.
We have generated $3.4 million in licensing revenues and actual cost savings (which are a full cash benefit) for Baptist.
And we have generated $11.5 million in new, philanthropic gifts.
This -- after only 3 years in, with 2.5 of those years being COVID years.
We ultimately and eventually expect the overall success, in due time, to be fully transformational to Baptist Health.
I believe that those results are heartening progress in about 3 years. I want to move you through time, albeit at warp speed, so you have a good sense of our momentum.
In 2019:
Barry Katzen and Baptist brought me on board as the first ever VP for corporate innovation
In 2020, we put basic infrastructure in place:
We created Miami Inno
We did a major deal with Philips
We adopted the first Baptist IP policy, a progressive policy that shares upside with Baptist inventors and subject matter experts in very generous ways.
We inked the deal for the Knight Fellowship I mentioned.
We did our first investment
And I started hiring our team
In 2021, we accelerated our progress
Our team focused on doing more deals
We made a strategic investment as a limited partner in Triventures
And we launched our $30 million innovation fund.
In 2022:
We focused on doing more of everything – more deals, more investments, more codevelopments, adding more Knight fellows
We also did a couple firsts: we launched that first start-up company I mentioned and we completed our first international license
In 2023:
We received that first-ever Baptist patent.
With these many accomplishments in place, we are on our way to joining the ranks of top health system innovators like Mayo Clinic, Mass General Brigham, MD Anderson, Cleveland Clinic, MD Anderson, and more.
We are fast followers in the health system innovators space, and we LOVE being in that position. Other top systems led – they are the pioneers with, as the saying goes, some arrows in their backs – and we follow and enjoy, presumably, some fantastic fast-follower benefits.
Earlier, I promised a review of our pathways.
On this graphic, our assets are BLUE
Our approaches – our verbs – are GREEN.
The outputs are shown on the right.
The way we think about our work is that Baptist has CORE ASSETS. You see those here as the hexagons. The Baptist core assets to harness for innovation activities are:
EXPERTISE and KNOW-HOW
DATA and databases
AND INVENTIONS like algorithms, tools, devices, and therapies.
Those are the CORE ASSETS that we uncover, organize, monetize, promote, and more.
We then have core continuous innovation CAPABILTIES that we apply to the assets we have uncovered and organized. Our team brings the unusual skill set to do what’s in the circles, namely:
Develop and use those assets
License them outwards and generate royalties
Invest in them
Consult based on them
And Teach and Learn with them, including sitting on boards and counsels related to them
Connecting these assets and capabilities with documentation and agreements and actions and words, each of them in their own way for each transaction, creates NEW PATHWAYS for innovation at Baptist Health South Florida. Every pathway is unique, but we usually think of four main paths we are creating at Baptist. Those are, we are helping all of Baptist, with its 35000 employees:
Monetize IP and Data
Leverage Know-how
Develop and co-develop inventions and products
And conduct Education and Training
Those pathways are like new neuronal networks in brains or new artery connections for heart function, in terms of innovation at Baptist. We’re trying out this “pathways” visual as a way of communicating what we do, so you’ll see this graphical representation throughout my individual project updates today.
And now a few examples.
By working with COTA, Baptist is improving treatment for cancer patients.
WHAT AND WHO
The company is bringing clarity to cancer care. It organizes real world data, or RWD, to guide clinical decisions and actions and has a particularly exciting application for precision medicine. We think it’s among the most exciting and pioneering companies in the cancer space today.
COTA is great example of a project collaboration with a Baptist Health Center of Excellence--in this case Miami Cancer Institute. The chief medical officer of MCI, Dr. Len Kalman, is the clinical leader of the Baptist-COTA collaboration. For the projects we discuss today, you’ll note that Innovations typically has a Center of Excellence, or Group, or Unit staff/clinician sponsor. They’re the ones who are dedicated to translational research and innovation, and we exist to support that dedication.
DEAL - PROJECT - PATHWAY
I want to bring you to the right side. In this particular project, Baptist:
Has a royalty bearing license with COTA, related to data, as well as a license with Dr Kalman
Uses the COTA technology in its own treatment of patients.
Also, Len and MCI are co-developing the tool (and using and validating it) with the COTA team.
Baptist is an investor in the company and
Baptist has two representatives on its board.
In general, that falls along the pathway of ensuring that Baptist Health Monetizes its IP and Data.
BENEFITS AND RESULTS
Ultimately, it’s all about benefits and impact.
The benefit of COTA to the world is (eventually) improved treatments for cancer patients.
Also, through COTA, we have generated millions in royalty revenues and collaboration fees as well as benefits of reduced data-abstraction costs.
PLUS, we hope or expect to enjoy a return on our equity investment, which could raise the overall financial value of the COTA relationship.
In working with Cleerly, Baptist is working to predict and prevent heart attacks.
WHAT AND WHO
Cleerly is reinventing coronary care by predicting heart attacks with interpretive reports from coronary CT scans. Ultimately, it will have a product for benchmarking against the progression of heart disease, thus enabling interventions for preventing heart attacks.
The collaboration is led on the Baptist staff and clinician side by Dr. Jonathan Fialkow who has joined me this week in Israel. He is deputy director at Miami Cardiac & Vascular Institute and chief of cardiology at Baptist Hospital
DEAL – PROJECT - PATHWAY
Baptist Health provides Cleerly with deidentified patient data from the Miami Heart Study, a long-term observational study of ~2,400 asymptomatic Miami-area residents and their genetics, lifestyle behaviors, risk factors and cardiovascular disease.
We have a royalty-bearing license to provide Cleerly with the data
We also are codeveloping the technology.
And we have an equity stake. We invested in the $200M+ round that was led by T. Rowe Price Associates, T. Rowe Price Investment Management, and Fidelity Management and Research.
Cleerly is another example of the pathway have created for Baptist to Monetize IP and Data.
RESULTS AND BENEFITS
A new tool that better predicts and prevents heart disease.
Royalty revenues
We expect to generate a return on investment. The equity round that Cleerly raised, and we participated in, was more equity capital than almost every other healthcare IT company in the U.S. in 2022.
EXTRA
In 2022, we made good progress with the company. We hosted intensive interaction between Cleerly and our cardiology team, exploring new research initiatives and a role for Cleerly in expanding the Miami Heart Study clinical activities.
In working with Israel’s Lynx.MD, Baptist Health is improving outcomes in cardiac care.
WHAT AND WHO
Lynx.MD, is a venture-stage entity committed to driving driving better patient outcomes
It has a data and medical intelligence platform that connects healthcare partners with real-world clinical and operational data for improved cardiac care
Most importantly, it does this securely and safely, so health providers can more easily share and gain better information about cardiac care around the world.
Dr. Fialkow is also the lead on this collaboration.
DEAL – PROJECT - PATHWAY
In the collaboration, Baptist has a non-exclusive license where Lynx would introduce Baptist to cardiology companies that may benefit from Baptist cardiology data, especially the Miami Heart Study.
Lynx is another example of the pathway we have created for Monetizing Data.
RESULTS & BENEFITS
Improved insight into our own cardiology data
Warm intoductions to potential cardiology firm data licensees.
And downstream licenses & royalty revenues
In closing, I want to share that while we focus on near-term, action- and return-oriented activities, we also selectively invest “upstream” in oour innovation capacity by nurtuting a culture of innovation.
Our flagship program for such is our Knight Foundation Fellowship, under which we develop innovation capabilities across Baptist Health and the South Florida community
OVERVIEW
Baptist received a $1 million grant to establish a program in healthcare technology innovation and raised an additional $1 million in matching funds. It was an exciting milestone for us because it represented the Knight Foundation’s largest award to a healthcare institution.
We established a professional development program that offers tremendous benefits throughout our community and is producing next generation innovators.
The program couples an innovation curriculum with experiential learning to highlight the importance of, and opportunities for, innovation in healthcare. In the inaugural year, world-class lecturers shared their innovation experiences with the 26 fellows. The speaker roster has included:
John Abele, founder of Boston Scientific
Peter Fitzgerald, international venture capitalist and co-founder of the Stanford BioDesign program and co-founder of Tel Aviv’s TriVentures
Rich Wilmot, global head of Philips Ventures
Several local entrepreneurs and inventors who share their innovation stories.
At the second cohort’s graduation, teams of fellows presented their ideas for filling unmet healthcare needs. Among other projects, they had ideas for:
Reducing burnout among care providers
Improving access to mental health resources for individuals suffering from PTSD, and
Easing administration of information entry into medical records by care providers.
Most impressive, however, are the fellows themselves, who represent diversity at its best. They came from many education levels; many areas of government, industry and academia; many levels of accomplishment; and many ages, ethnicities and backgrounds.
In June 2022, we graduated that inaugural cohort of 26 people. Lat year, it expanded to 40 fellows, balanced among Baptist and community employment.
We just recently selected our 3rd Cohort of fellows, and we are excited to meet them and to support their contributions to the burgeoning South Florida entrepreneurial landscape.
In summary, the Knight Foundation Fellowship in Healthcare Technology Innovation surpassed even the high expectations set for it by Baptist Health Innovations.
We are teaching the lifelong learning mindset and a continuous innovation mindset
By five years in, the Program will have graduated approximately 200 South Florida innovators who will lead regional healthcare innovation for years to come. They can serve as the conduit and active network for healthcare innovation in the burgeoning South Florida region, with Baptist at its center.
Continuing on the theme of investing, an important component of Baptist Health Innovations is our Innovation Fund, CRITICALLY, this is a fund for making investments in organizations for which we have ALREADY established a working relationship with innovative companies via one of the innovation pathways I have described.
Equity investments are a key aspect of our investment strategy, and we have about $21 million remaining in our Innovation Fund.
I have really appreciated a chance to share a bit about Baptist Health and what we’ve begun in the innovations sector.
I look forward to questions and, more importantly, continued interaction with you, Sheba and its affiliates.